Relationship between prepregnancy anthrax vaccination and pregnancy and birth outcomes among US army women

被引:33
作者
Wiesen, AR [1 ]
Littell, CT [1 ]
机构
[1] Madigan Army Med Ctr, Dept Prevent Med, MCHJ PV, Tacoma, WA 98431 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 287卷 / 12期
关键词
D O I
10.1001/jama.287.12.1556
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Substantial concern surrounds the potential health effects of the anthrax vaccine, particularly the-potential adverse effects on reproductive processes. Objective To determine whether receipt of anthrax vaccination by reproductive-aged women has an effect on pregnancy rates. Design, Setting, and Patients Cohort study, based on information from a computer database, of women aged 17 to 44 years who were stationed at Fort Stewart, Ga, or Hunter Army Airfield, Ga, from January 1999 through March 2000. Main Outcome Measures Pregnancy and birth rates and adverse birth outcomes. Results Of a total of 4092 women, 3136 received at least 1 dose of the anthrax vaccine. There was a total of 513 pregnancies, with 385 following at least 1 dose of anthrax vaccine. The pregnancy rate ratio (before and after adjustment for marital status, race, and age) comparing vaccinated with unvaccinated women was 0.94 (95% confidence interval [CI], 0.8-1.2; P=.60). There were 353 live births and 25 pregnancies lost to follow-up. The birth odds ratio after anthrax vaccination (before and after adjustment for marital status and age) was 0.9 (95% CI, 0.5-1.4; P=.55). After adjusting for age, the odds ratio for adverse birth outcome after receiving at least 1 dose of anthrax vaccination was 0.9 (95% CI, 0.4-2.4; P=.88). However, this study did not have sufficient power to detect adverse birth outcomes. Conclusion Anthrax vaccination had no effect on pregnancy and birth rates or adverse birth outcomes.
引用
收藏
页码:1556 / 1560
页数:5
相关论文
共 28 条
[1]  
*ADV COMM IMM PRAC, 1994, MMWR-MORBID MORTAL W, V43, P20
[2]  
American College of obstetricians and gynecologists, 1993, INT J GYNECOL OBSTET, V40, P69
[3]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[4]  
[Anonymous], MORBIDITY MORTALITY
[5]  
Biological products, 1985, FED REGISTER, V50, P51002
[6]   FIELD-EVALUATION OF A HUMAN ANTHRAX VACCINE [J].
BRACHMAN, PS ;
FEKETY, FR ;
GOLD, H ;
WERRIN, M ;
INGRAHAM, NR ;
PLOTKIN, SA .
AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1962, 52 (04) :632-+
[7]  
Chin J., 2000, CONTROL COMMUNICABLE, V17th, P20
[8]   Biological warfare - A historical perspective [J].
Christopher, GW ;
Cieslak, TJ ;
Pavlin, JA ;
Eitzen, EM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (05) :412-417
[9]   The effectiveness and safety of vaccines against human anthrax: a systematic review [J].
Demicheli, V ;
Rivetti, D ;
Deeks, JJ ;
Jefferson, T ;
Pratt, M .
VACCINE, 1998, 16 (9-10) :880-884
[10]   Anthrax [J].
Dixon, TC ;
Meselson, M ;
Guillemin, J ;
Hanna, PC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (11) :815-826